Riskpilot← Back to searchSign inGet full accessDr Hål AB
ABActiveOrg 5592065121Krimlanns Gård 47Construction of residential and non-residential buildings · NACE 4100Est. 20193 employees
Revenue 2025
SEK 4,3M
-29% vs 2024
EBITDA margin
-0.2%
+98% vs 2024
Equity ratio
39.7%
Financial strength
Net profit 2025
SEK -14K
+96% vs 2024
| Revenue | SEK 4,3M | -29% |
| EBITDA | SEK -8K | +98% |
| Net profit | SEK -14K | +96% |
| Total assets | SEK 927K | -15% |
| Equity | SEK 368K | -4% |
| Employees | 3 | — |
Legal name
Dr Hål AB
Org number
5592065121
Legal form
Aktiebolag
NACE code
4100 · Construction of residential and non-residential buildings
Founded
21 maj 2019
Share capital
SEK 51 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva byggtjänster med specialinriktning på betongarbeten och betonghåltagning samt därmed förenlig verksamhet.
Address
Krimlanns Gård 47
Email
kalle@drhal.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 358 | 5 337 | 8 437 | 6 057 | 4 281 |
| Staff expenses | — | — | −2 869 | −2 511 | −1 791 |
| EBITDA | −201 | 492 | 83 | −331 | −8 |
| Depreciation & amort. | −24 | −27 | −27 | −25 | −0 |
| EBIT | −225 | 465 | 56 | −357 | −8 |
| Net financials | — | −1 | −14 | −11 | −6 |
| Profit before tax | −85 | 464 | 41 | −367 | −14 |
| Tax | −0 | −98 | — | — | — |
| Net profit | −85 | 366 | 41 | −367 | −14 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 944 | 1 134 | 1 880 | 1 088 | 927 |
| Equity | 341 | 708 | 749 | 382 | 368 |
| Long-term debt | 0 | 0 | 255 | 131 | 82 |
| Short-term debt | 603 | 426 | 877 | 575 | 477 |
| Total debt | 603 | 426 | 1 131 | 707 | 559 |
EBITDA margin
-0.2%
This company
15.8%
Market median
-101% vs market
20212025
Equity ratio
39.7%
This company
38.2%
Market median
+4% vs market
20212025
Return on equity
-3.8%
This company
18.4%
Market median
-121% vs market
20212025
Net profit margin
-0.3%
This company
8.1%
Market median
-104% vs market
20212025
Asset turnover
4.62×
This company
1.12×
Market median
+312% vs market
20212025
Debt / equity
1.52×
This company
0.62×
Market median
-145% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Chairman | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Hål AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Roland Wistrand | Chairman | 0 companies |
| Magnus Olof Holmdahl | Deputy Board Member | 0 companies |
| Kalle Ask | Board of Directors | 0 companies |